Acutaas Chemicals Limited shareholders rejected the special resolution to grant employee stock options to employees of subsidiary companies under the 'Ami Organics Employees Stock Option Scheme 2023' during the 19th Annual General Meeting held on September 24, 2026.

The resolution failed to secure the requisite 75% majority, receiving only 72.63% votes in favour. Institutional investors led the opposition, casting 57.67% of their polled votes against the proposal. All other ordinary and special business items were approved by the members.

Voting Results Breakdown

The scrutinizer’s report confirmed that eight out of nine resolutions passed with overwhelming support. The rejection of the ESOP scheme stands out as the sole dissenting vote among the agenda items.

Institutional Opposition to ESOP Proposal

The ESOP resolution faced significant resistance from the public institutional shareholder base. While promoters and promoter group voted unanimously in favour, institutions holding 34,590,629 shares polled 29,074,686 votes against the scheme. This represented 57.67% of the total votes cast by institutions on this specific item.

In contrast, public non-institutional shareholders largely supported the measure, with 99.99% of their polled votes in favour. The disparity between institutional and retail voting patterns directly contributed to the resolution's failure to cross the 75% threshold required for special resolutions.

Approval of Dividend and Financials

Shareholders adopted the audited standalone and consolidated financial statements for FY26 and approved the declaration of a final dividend. The dividend resolution passed with 99.9998% of votes in favour.

Other key approvals included:

• Re-appointment of Mr. Chetankumar C. Vaghasia as Whole Time Director (97.48% in favour).
• Re-appointment of Mr. Ram Mohan Lokhande as Whole Time Director (99.88% in favour).
• Re-appointment of Dr. Anita Bandyopadhyay as Independent Director for a second term (97.78% in favour).
• Approval of material related party transactions with Acutaas Chemicals Electrolytes Private Limited (99.9995% in favour).

Meeting Logistics and Attendance

The meeting was held virtually via video conferencing from the company’s registered office in Mumbai. Mr. Nareshkumar R. Patel, Chairman and Managing Director, presided over the session. The record date for voting entitlement was September 17, 2026, with 1,45,546 registered shareholders.

A total of 86 members attended the virtual meeting, comprising two from the promoter group and 84 public shareholders. Remote e-voting facilities were provided by MUFG Intime India Pvt. Ltd. from September 21 to September 23, 2026. The scrutinizer’s report was submitted by Kashyap Shah & Co., Practising Company Secretaries.

Acutaas Chemicals Limited approved the acquisition of 100% share capital of Enchem Ami Organics Private Limited (EAOPL), its step-down subsidiary. The move transforms EAOPL into a direct wholly owned subsidiary of the specialty chemicals firm.

The Board of Directors granted approval at a meeting held on September 24, 2026. The acquisition involves the transfer of shares from Acutaas Chemicals Electrolytes Private Limited (ACEPL), the current parent of EAOPL, directly to Acutaas Chemicals. This restructuring simplifies the corporate hierarchy without altering operational control.

Acquisition Details

The transaction is classified as a related party transaction because EAOPL is already part of the group structure. The shares were transferred at face value, ensuring an arm's length basis for the internal reorganization. No external regulatory approvals are required for this intra-group transfer.

Target Entity Profile

EAOPL was incorporated on June 6, 2024, under the Companies Act, 2013. It operates in the specialty chemicals sector with presence in India. The entity has not yet commenced revenue-generating activities, reporting nil turnover for both FY25 and FY26.

The authorized and paid-up share capital of EAOPL stands at ₹1,00,000, divided into 10,000 equity shares of ₹10 each. Upon completion of the acquisition, EAOPL will cease to be a step-down subsidiary and will operate as a direct wholly owned subsidiary of Acutaas Chemicals.

What the Numbers Show

The acquisition cost of ₹1,00,000 matches the total paid-up capital of EAOPL exactly, reflecting a transfer at face value rather than a market-based valuation. This pricing aligns with the entity's current status as a non-operational shell company with zero revenue since its incorporation in June 2024. The transaction serves primarily as a structural consolidation, bringing a dormant specialty chemicals vehicle directly under the listed parent's umbrella.